CureSearch Roundtable featuring Dr. Lee

Join our virtual roundtable with Dr. John Lee, a CureSearch Acceleration Initiative Awardee at the David Geffen School of Medicine at UCLA. Learn more about his groundbreaking IL-18 armored STEAP1 CAR T cell therapy for Ewing sarcoma—a fourth-generation immunotherapy poised to launch clinical trials in 2026 that could transform treatment for children with advanced disease.




